Would have been a few newcomers to CSL yesterday.
Any newbs not yet aware on the trial of CSL 112....here you go.
Is there anything in that R&D pipeline that you’re particularly interested in?
Yes, there's a trial that they're running called CSL112. It's a potentially company changing drug. CSL112 is designed to remove cholesterol from plaques in the arteries which can lead to heart attacks or stroke events. The company is currently part way through a phase 3 trial, fully funded and expensed by themselves.
This product has a large market opportunity with a high unmet need. If the product is proven it could end up generating revenue up to a third of the current immunoglobulin business at very high margin. There is additional value created if this product is successful driven by the last litre economics of the fractionation process, that is to say, this product can be manufactured out of the existing raw materials driving margin up for the overall business.
- Forums
- ASX - By Stock
- CSL
- Why CSL is cheaper than you think
Why CSL is cheaper than you think, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$296.00 |
Change
-0.690(0.23%) |
Mkt cap ! $143.3B |
Open | High | Low | Value | Volume |
$296.70 | $297.28 | $295.09 | $108.7M | 367.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 929 | $295.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$296.44 | 474 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 929 | 295.960 |
1 | 1264 | 295.870 |
1 | 75 | 295.810 |
1 | 50 | 295.750 |
1 | 1264 | 295.710 |
Price($) | Vol. | No. |
---|---|---|
296.440 | 474 | 1 |
296.710 | 96 | 1 |
296.940 | 1264 | 1 |
296.980 | 50 | 1 |
297.000 | 550 | 5 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |